花园生物：2025年前三季度净利润约2.34亿元

Core Viewpoint - Garden Biologics reported a slight decline in revenue and net profit for the third quarter of 2023, indicating potential challenges in maintaining growth in a competitive market [1] Financial Performance - Revenue for the first three quarters of 2025 was approximately 936 million yuan, a year-on-year decrease of 0.2% [1] - Net profit attributable to shareholders was around 234 million yuan, reflecting a year-on-year decline of 3.07% [1] - Basic earnings per share were 0.43 yuan, down 4.44% compared to the previous year [1]